-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

902. Health Services Research—Lymphoid Malignancies: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 12, 2021: 6:00 PM-8:00 PM
Hall B5, Level 1, Building B (Georgia World Congress Center)

Kimberley Doucette, MD1, Allison Taylor, MD, MS2, Bryan Chan, MPH3*, Xiaoyang Ma, MS3*, Jaeil Ahn, PhD4*, David H. Vesole, MD, PhD5 and Catherine Lai, MD, MPH6

1Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC
2Internal Medicine, Duke University School of Medicine, Durham
3Lombardi Comprehensive Cancer Center, Medstar Georgetown University Hospital, Washington, DC
4Georgetown University, Department of Biostatistics, Bioinformatics, and Biomathematics, Washington D.C.
5John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
6Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC

Clark Dumontier, MD, MPH1,2,3*, Tim Jaung, MS4*, Nupur E. Bahl, BS4*, Emily S. Magnavita, MPH4*, Brad Manor, PhD3,5*, Marcia Testa, MPH, Mphil, PhD6*, Dae Kim, MD, ScD, MPH3,5*, Tammy T. Hshieh, MD, MPH2,3,4*, Jane Driver, MD, MPH2,3,7* and Gregory A. Abel, MD, MPH4,8

1New England Geriatric Research Education and Clinical Center, Boston, MA
2Brigham and Women's Hospital, Boston, MA
3Harvard Medical School, Boston, MA
4Dana-Farber Cancer Institute, Boston, MA
5Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, MA
6Harvard T.H. Chan School of Public Health, Boston, MA
7New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System, Boston, MA
8Center for Bioethics, Harvard Medical School, Boston, MA

Ron Rabinowicz, MD1*, Johann K Hitzler, MD2 and Angela Punnett, MD3*

1The Hospital for Sick Children, Toronto, ON, Canada
2Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada
3Hospital for Sick Children, Toronto, ON, Canada

Hetalkumari Patel, PharmD1*, Svea K. Wahlstrom, VMD, MS2*, Maral DerSarkissian, PhD3*, Colin Kunzweiler, PhD, MS4*, Felicia Castriota, MPH, PhD4*, Rose Chang, MSPH, MS, ScD4*, Hoi Ching Cheung, BA4*, Yuqian Gu, MS3*, Helen Guo, BA3*, Mei Sheng Duh, ScD, MPH4 and Kellie J. Ryan, MPH2*

1UT Southwestern Medical Center, Dallas, TX
2AstraZeneca, Gaithersburg, MD
3Analysis Group, Inc., Los Angeles, CA
4Analysis Group, Inc., Boston, MA

Maria Teresa Petrucci, MD1, João Mendes2*, Jennifer H. Boer3*, Gabriele Casamassima4*, Anna Willis5*, Astrid Ottosson Wadlund6*, Suzette Matthijsse3* and Patrizio Armeni7*

1Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
2Janssen Cilag, Porto Salvo, Portugal
3BresMed, Utrecht, Netherlands
4Janssen Cilag Spa, Milan, NC, ITA
5BresMed, Sheffiel, United Kingdom
6Janssen Cilag AB, Solna, Sweden
7Cergas (Centre for Research on Health and Social Care Management), SDA Bocconi School of Management,, Milan, Italy

Amanda Ribbands1*, Boris Gorsh, PharmD2*, Abigail Bailey1*, Natalie Boytsov, PhD2*, Emily Luke1*, Annabel Lambert1* and Cosmina Hogea, PhD3*

1Adelphi Real World, Bollington, United Kingdom
2GlaxoSmithKline, Upper Providence, PA
3GlaxoSmithKline (at time of study), Upper Providence, PA

Rongrong Wang, MPH*, Josh Roth*, Carmen Ng*, Farah Hossain*, Jia Li and Anthony Masaquel*

Genentech, Inc., South San Francisco, CA

Christopher Parker, MSc1*, Fei Fei Liu, BSc, MBA2*, Kristen Deger, MS3*, Conrado Franco-Villalobos, MSc4*, Irina Proskorovsky, M.Sc4*, Scott J Keating, MS2*, Sonja Sorensen, MPH3* and Emily Dorman, MPH3*

1Bristol Myers Squibb, Uxbridge, United Kingdom
2Bristol Myers Squibb, Princeton, NJ
3Evidence Synthesis, Modeling & Communication, Evidera Inc., Bethesda, MD
4Evidence Synthesis, Modeling & Communication, Evidera Inc., Montreal, QC, Canada

Tu My To*, Jamie T. Ta, PharmD, MS*, Arpamas Seetasith, PhD*, Rongrong Wang, MPH*, Dominic Lai, PharmD* and Sheila Shapouri, PharmD, MS*

Genentech, Inc., South San Francisco, CA

Aman Wadhwa, MD, Kathryn Six, MD*, Smita Bhatia, MD, MPH and Kelly Kenzik, PhD*

Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL

Lucy Morgan, MPhil1*, Christine Merkel, MSc1*, Leo I. Gordon, MD2, John Buscombe, MD3*, Suzanne Wait, PhD1*, Martin H. Dreyling, MD, PhD4, Erik Mittra, MD, PhD5* and Ajay K Gopal, MD6

1The Health Policy Partnership, London, United Kingdom
2Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Northwestern University, Chicago, IL
3Barts Health NHS Trust, London, United Kingdom
4Department of Internal Medicine III, LMU Hospital, Munich, Germany
5Oregon Health & Science University, Portland, OR
6University of Washington/Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA

Md Imran Hossain1*, Peter Hampson2*, Craig Nowell2*, Shamshad Khan3*, Ranjoy Sen1*, Sharadha Sundararaman4*, Jagdish Adiyodi1* and Supratik Basu5*

1East Lancashire Hospitals NHS Trust, Burnley, United Kingdom
2The Binding Site, Birmingham, United Kingdom
3Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, United Kingdom
4West Midlands University Hospitals Coventry and Warwickshire, Coventry, United Kingdom
5The Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom

Sudip Bhandari, PhD1*, Charles Lagor, MD, PhD, MBA2*, Judith Mueller, PhD2*, Warren Whyte, PhD2* and Samuel Heilbroner, MD2*

1ConcertAI, Baltimore, MD
2ConcertAI, Boston, MA

Rahul Banerjee, MD1, Bella Sykes, B.S.2*, Nina Shah, MD1, Charalambos Andreadis, MD, MSCE1*, Peter H. Sayre, MD, PhD1, Thomas Martin, MD1, Jason Shore, MBA2*, Adam Sodowick2* and Sandy W. Wong, MD3

1University of California San Francisco, San Francisco, CA
2Patient Discovery Solutions, Inc., Newton, MA
3Department of Medicine, University of California San Francisco, San Francisco, CA

Aditi Sharma, MD1*, Vijendra Singh, MD2 and Abhinav Deol2

1Wayne State University, Detroit, MI
2Karmanos Cancer Institute, Wayne State University, Detroit, MI

Neda Alrawashdh, PharmD1*, Ali McBride, PharmD, MSc2 and Ivo Abraham, PhD, RN3

1Center for Health Outcomes and Pharmacoeconomic Research, university of arizona, TUCSON, AZ
2Department of Pharmacy Practice and Science, The University of Arizona College of Pharmacy, Tucson, AZ
3Center for Health Outcomes and PharmacoEconomic Research, University of Arizona - College of Pharmacy, Tucson, AZ

Rebecca Crawford, MA1*, Verna L Welch, PhD, MPH2*, Richa Shah, PharmD2, Lynda Doward, MRes1* and Cheryl Truchan, MBA2*

1RTI Health Solutions, Manchester, United Kingdom
2Pfizer Inc., New York, NY

*signifies non-member of ASH